Phillip McGaha
Pediatrics · Charleston, SCNPI 1295786556
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 132 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 11.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $544 and has fallen 52.1% since, to $261 in 2025. Among pediatrics clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 132 payments — averaging $18.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$284
- Corium, LLC$252
- GSK$244
- Ironshore Pharmaceuticals Inc.$215
- Neos Therapeutics, LP$210
- Supernus Pharmaceuticals, Inc.$171
- plus $1K from 15 others
Across 40 payments — averaging $7322.05 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi Pasteur Inc.$240K
- Modernatx, Inc.$24K
- Biohaven Pharmaceutical Holding Company Ltd.$23K
- Lumos Diagnostics, Inc.$3K
- Pfizer$3K
What the payments were for
- Food & beverage$2,393100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 15 | $284 |
| Corium, LLC | 11 | $252 |
| GSK | 14 | $244 |
| Ironshore Pharmaceuticals Inc. | 12 | $215 |
| Neos Therapeutics, LP | 17 | $210 |
| Supernus Pharmaceuticals, Inc. | 5 | $171 |
| Sanofi-aventis U.S. LLC | 5 | $149 |
| Adlon Therapeutics L.p. | 10 | $147 |
| Tris Pharma Inc | 8 | $143 |
| Seqirus USA Inc | 6 | $106 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $98 |
| Sobi, Inc | 5 | $87 |
| Sanofi Pasteur Inc. | 4 | $57 |
| Collegium Pharmaceutical, Inc. | 3 | $48 |
| Merck | 3 | $47 |
| Shire North American Group Inc | 3 | $44 |
| Verrica Pharmaceuticals Inc. | 1 | $26 |
| Genentech USA, Inc. | 1 | $21 |
| Biomarin Pharmaceutical Inc. | 1 | $17 |
| Ultragenyx Pharmaceutical Inc. | 1 | $15 |
| Biogen | 1 | $13 |
How this compares
$2,393 in reported general payments places this provider in the 95th percentile of 969 pediatrics providers in South Carolina.
Other pediatrics in Charleston
- Stephen StriplingCharleston$31K
- Robert CliffordCharleston$8K
- James McElligottCharleston$6K
- John TraynhamCharleston$4K
- Todd VaskoCharleston$3K
- Aimee GoedeckeCharleston$2K
- Micah VaskoCharleston$2K
- Christina CuffCharleston$2K
- Vanessa AdamsCharleston$2K
- William JarvisHilton Head Island$78K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.